1 Min Read
June 8 (Reuters) - Paion AG :
* Announces initiation of second U.S. Phase III clinical trial of Remimazolam for procedural sedation during bronchoscopy Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.